全文获取类型
收费全文 | 4629篇 |
免费 | 234篇 |
国内免费 | 38篇 |
专业分类
耳鼻咽喉 | 61篇 |
儿科学 | 211篇 |
妇产科学 | 160篇 |
基础医学 | 436篇 |
口腔科学 | 213篇 |
临床医学 | 359篇 |
内科学 | 1039篇 |
皮肤病学 | 90篇 |
神经病学 | 293篇 |
特种医学 | 99篇 |
外科学 | 647篇 |
综合类 | 246篇 |
一般理论 | 18篇 |
预防医学 | 221篇 |
眼科学 | 148篇 |
药学 | 373篇 |
中国医学 | 82篇 |
肿瘤学 | 205篇 |
出版年
2024年 | 3篇 |
2023年 | 40篇 |
2022年 | 162篇 |
2021年 | 251篇 |
2020年 | 114篇 |
2019年 | 143篇 |
2018年 | 191篇 |
2017年 | 93篇 |
2016年 | 114篇 |
2015年 | 181篇 |
2014年 | 193篇 |
2013年 | 236篇 |
2012年 | 343篇 |
2011年 | 414篇 |
2010年 | 211篇 |
2009年 | 191篇 |
2008年 | 297篇 |
2007年 | 236篇 |
2006年 | 259篇 |
2005年 | 243篇 |
2004年 | 219篇 |
2003年 | 173篇 |
2002年 | 199篇 |
2001年 | 45篇 |
2000年 | 17篇 |
1999年 | 38篇 |
1998年 | 31篇 |
1997年 | 26篇 |
1996年 | 23篇 |
1995年 | 14篇 |
1994年 | 17篇 |
1993年 | 12篇 |
1992年 | 17篇 |
1991年 | 15篇 |
1990年 | 15篇 |
1989年 | 18篇 |
1988年 | 11篇 |
1987年 | 8篇 |
1986年 | 12篇 |
1985年 | 4篇 |
1984年 | 6篇 |
1983年 | 8篇 |
1982年 | 12篇 |
1981年 | 10篇 |
1980年 | 7篇 |
1979年 | 2篇 |
1978年 | 7篇 |
1977年 | 5篇 |
1976年 | 9篇 |
1974年 | 3篇 |
排序方式: 共有4901条查询结果,搜索用时 15 毫秒
1.
2.
M. Perwaiz Iqbal M. Khalid Ashfaq Sarfaraz K. Niazi M. Mahboobali Khalid N. Khawaja 《Biopharmaceutics & drug disposition》1994,15(2):173-177
Pharmacokinetic parameters of two antifolates, trimethoprim and aditoprim, were studied in buffalo calves. The elimination half-life of aditoprim (6.14 h) was nearly twice as long as that of trimethoprim (3.08 h) and compares well with values observed in heifers. This longer half-life of aditoprim is a result of its much larger distribution volume (four to five times larger) because the clearance of aditoprim was about twice as high as that of trimethoprim. The longer half-life of aditoprim is expected to give a longer duration of in vivo bacteriostatic activity than that of trimethoprim. 相似文献
3.
4.
Ahmed M. Abu El-Asrar Eman S. Kahtani Khalid F. Tabbara 《Documenta ophthalmologica. Advances in ophthalmology》1995,89(4):313-320
In this report we describe, herewith, a patient with primary pigmentary dystrophy of the retina (retinitis pigmentosa) associated with unilateral retinal arteriovenous communication and exudative retinal detachment. The patient had complete resolution of the retinal detachment following laser photocoagulation treatment. Such association has not been previously reported. 相似文献
5.
Evolution of Vascular Access 总被引:1,自引:0,他引:1
6.
Steven R. Alexander Gerald S. Arbus Khalid M. H. Butt Susan Conley Richard N. Fine Ira Greifer Alan B. Gruskin William E. Harmon Paul T. McEnery Thomas E. Nevins Nadia Nogueira Oscar Salvatierra Jr Amir Tejani 《Pediatric nephrology (Berlin, Germany)》1990,4(5):542-553
This report of the North American Pediatric Transplant Cooperative Study summarizes data contributed by 57 participating centers on 754 children with 761 transplants from 1 January 1989 to 16 February 1989. Data collection was initiated in October 1987 and follow-up of all patients is ongoing. Transplant frequency increased with age; 24% of the patients were less than 5 years, with 7% being under 2 years. Common frequent diagnoses were: aplastic/dysplastic kidneys (18%), obstructive uropathy (16%), and focal segmental glomerulosclerosis (12%). Preemptive transplant, i.e., transplantation without prior maintenance dialysis, was performed in 21% of the patients. Dialytic modalities pretransplant were peritoneal dialysis in 42% and hemodialysis in 25%. Bilateral nephrectomy was reported in 29%. Live-donor sources accounted for 42% of the transplants. Among cadaveric donors, 41% of the donors were under 11 years old. During the first post-transplant month, maintenance therapy was used similarly for live-donor and cadaver source transplants, with prednisone, cyclosporine, and azathioprine used in 93%, 83%, and 81%, respectively. Triple therapy with prednisone, cyclosporine, and azathioprine was used in 78%, 75%, and 75% of functioning cadaver source transplants at 6 months, 12 months, and 18 months as opposed to 60%, 63%, and 54% for live-donor procedures, with single-drug therapy being uncommon. Rehospitalization during months 1–5 occurred in 62% of the patients, with treatment of rejection and infection being the main causes. Additionally, 9% were hospitalized for hypertension. During months 6–12 and 12–17, 30% and 28% of the patients with functioning grafts were rehospitalized. Times to first rejection differed significantly for cadaver and live-donor transplants. The median time to the first rejection was 36 days for cadaver transplants and 156 days for live-donor transplants. Overall, 57% of treated rejections were completely reversible although the complete reversal rate decreased to 37% for four or more rejections. One hundred and fifty-two graft failures had occurred at the time of writing, with a 1-year graft survival estimate of 0.88 for live-donor and 0.71 for cadaver source transplants. In addition to donor source, recipient age is a significant prognostic factor for graft survival. Among cadaver donors, decreasing donor age is associated with a decreasing probability of graft survival. Thirty-five deaths have occurred; 16 attributed to infection and 19 to other causes. The current 1-year survival estimate is 0.94. There have been 9 malignancies.A list of all participating centers and the names of the investigators is printed on pages 552–553 相似文献
7.
Mohammad Khalid Jamal M.D. Eric J. DeMaria M.D. Jason M. Johnson D.O. Brennan J. Carmody M.D. Luke G. Wolfe M.S. John M. Kellum M.D. Jill G. Meador R.N. 《Surgery for obesity and related diseases》2005,1(6):655-516
BACKGROUND: We hypothesized that major co-morbidities affect survival and complications after gastric bypass. METHODS: A total of 1465 patients undergoing laparoscopic and open gastric bypass between 1995 and 2002 were studied. Patients with a body mass index >or= 35 kg/m(2) and major co-morbidities (group 1, n = 1045) were compared with patients with a body mass index >or= 40 kg/m(2) with minor/no co-morbidities (group 2, n = 420). RESULTS: Group 1 patients were older (43 versus 36 years, P < 0.001) and had a greater BMI (53 versus 50 kg/m(2), P < 0.001). Early postoperative complications were greater in group 1 than in group 2 and included leaks (4.1% versus 1.2%, P < 0.0032) and wound infections (3.9% versus 1.4%, P < 0.0133). Procedure-related mortality in the series was 1.7%. Mortality was 10-fold greater in group 1 (2.3% versus 0.2%, P < 0.0032). The incidence of small bowel obstruction, incisional hernia, and pulmonary embolism was similar in the two groups. Excess weight loss was significantly greater in group 2 (68% versus 62%, P < 0.001) at 1 year. Resolution of group 1 co-morbidities was great, including hypertension in 62%, diabetes in 75%, venous stasis disease in 96%, and pseudotumor cerebri in 98%. CONCLUSION: Outcomes analysis of obesity surgery requires risk stratification. The very low mortality rates in published studies are likely explained by surgical treatment of low-risk patients with minor co-morbidities, such as those seen in group 2. However, despite the increased perioperative risk, the group 1 patients (with major co-morbidities) demonstrated dramatic resolution of their co-morbid conditions, justifying the decision to go forward with surgery. The data support a radical change in treatment philosophy in which morbidly obese individuals should be offered bariatric surgery before major co-morbid conditions develop as a strategy to decrease the operative risk. 相似文献
8.
The clinical aspects of peritonitis and catheter infections were reviewed in 64 children on continuous ambulatory peritoneal
dialysis living in Saudi Arabia over a period of 6 years. Peritonitis occurred in 41 children (64%). The mean time from starting
dialysis to the first episode of peritonitis was 7.2 months. The incidence of peritonitis was 1 episode in 9 treatment months.
Gram-negative organisms were responsible for the majority of episodes (42%), followed by Gram-positive organisms (20%), and
Candida albicans (6%); 32% were culture negative. Recurrent peritonitis was present in 20 cases. Catheter was replaced in 24 patients: 44%
due to recurrent peritonitis. Peritoneal membrane loss occurred in 7 patients, 3 had Candida peritonitis and 3 had recurrent peritonitis due to Pseudomonas. The mortality rate was 4.6% but none of the deaths were related to peritonitis or dialysis.
Received August 23, 1995; received in revised form October 2, 1996; accepted October 18, 1996 相似文献
9.
10.
Ruszymah BH Nabishah BM Aminuddin S Sarjit S Khalid BA 《The Malaysian journal of pathology》1999,21(1):51-58
Corticotrophin releasing factor (CRF) and beta-endorphin (beta EP) containing neurons are shown to be present in the hypothalamus and both neurons are found at the paraventricular nucleus (PVN). Steroid hormones have been found to alter the plasma level of these neurotransmitters. Glycyrrhizic acid (GCA) is the active component of liquorice. GCA inhibits the enzyme 11 beta-hydroxysteroid dehydrogenase (11HSD) which is needed for the inactivation of the steroid pathway, so therefore would cause changes to these neurons. The aim of this study was to investigate the effects of GCA as well as deoxycorticosterone (DOC) and dexamethasone (DM) on the modulation of CRF and beta EP containing neuron at the PVN of the hypothalamus. Rats were given either DM, DOC or GCA and adrenalectomized (ADX) and given either DM or DOC. At the end of treatment rats were transfused transcardially before sacrifice and the brain were dissected for immunohistochemical analysis. We found that immunostaining of the CRF containing neurons demonstrate a reduction in the number of positive neurons in DM treated rats. DOC and GCA treated rats showed the same result as in DM rats but the reduction is less. ADX, DM, DOC and GCA treated rats did not show any changes in the number of beta EP containing neurons but naloxone increased the number of beta EP containing neurons markedly. In conclusion, GCA and DOC have similar effects on CRF and beta EP containing neurons at the PVN. 相似文献